Shumei Man, MD, PhD, on Shortening Door-to-Needle Times in Acute Ischemic Stroke
In this podcast, Dr Man discusses the findings from her recent study, which indicated that shorter thrombolytic door-to-needle times were associated with lower all-cause readmission and lower all-cause mortality at 1 year among Medicare beneficiaries aged 65 years or older with acute ischemic stroke. For more podcasts like this, visit www.consultant360.com/neurology.